LBF20406LT09: Difference between revisions

No edit summary
No edit summary
Line 6: Line 6:
|LipidBank=XPR3118
|LipidBank=XPR3118
|LipidMaps=LMFA03020016
|LipidMaps=LMFA03020016
|SysName=(5S,12R) -Dihydroxy- (6-cis,8-trans,10-trans,14-cis) -icosatetraenoic acid
|SysName=(5S,12R) -Dihydroxy- (6-cis,8-trans,10-trans,14-cis) -eicosatetraenoic acid
|Common Name=&&20-carboxy Leukotriene B_4&&(5S,12R) -Dihydroxy- (6Z,8E,10E,14Z) -eicosatetraenoic acid
|Common Name=&&20-carboxy Leukotriene B_4&&(5S,12R) -Dihydroxy- (6Z,8E,10E,14Z) -eicosatetraenoic acid
|Source=20-carboxy LTB4 is a metabolite of LTB4 in human neutrophils
|Source=20-carboxy LTB4 is a metabolite of LTB4 in human neutrophils

Revision as of 07:45, 2 June 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



20-carboxy Leukotriene B4
LBF20406LT09.png
Structural Information
(5S,12R) -Dihydroxy- (6-cis,8-trans,10-trans,14-cis) -eicosatetraenoic acid
  • 20-carboxy Leukotriene B4
  • (5S,12R) -Dihydroxy- (6Z,8E,10E,14Z) -eicosatetraenoic acid
Formula C20H30O6
Exact Mass 366.204238692
Average Mass 366.4486
SMILES C(CCCC(O)=O)C=CC[C@H](C=CC=CC=C[C@H](CCCC(O)=O)O)O
Physicochemical Information
20-carboxy LTB4 is a metabolite of LTB4 in human neutrophils
The biological activity of 20-carboxy LTB4 is only about 2.6% compared to that of LTB4 in causing PMNL degradation. Feinmark_SJ et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20406LT09 See above. Feinmark_SJ et al. 1981